Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet
Oleg Milberg, PhD
Director Quantitative Pharmacology
Regeneron Pharmaceuticals, Inc.
Poster(s):
(M-076) Methodology of the Exposure-Response (E-R) Analysis of Linvoseltamab in Patients with Relapsed/Refractory (RR) Multiple Myeloma (MM)
Monday, November 11, 2024
7:00 AM – 5:00 PM
MST
Email Oleg
